Mark A. Velleca, President and CEO at G1 Therapeutics, Inc. (GTHX), sold 10,000 shares at $42.01 ($415K) on 2018-10-15, disclosed to the SEC on 2018-10-15.
Open-market sale of $415k GTHX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.90 | 2,163 | $88K | 21.3% |
| 2 | $40.90 | 2,163 | $88K | 21.3% |
| 3 | $42.01 | 2,837 | $119K | 28.7% |
| 4 | $42.01 | 2,837 | $119K | 28.7% |
| Total | $41.53 avg | 10,000 | $415K | 100% |
| Filing → |
| GTHX | SELL | 2022-09-22 | $270K | — | Filing → |
| GTHX | SELL | 2022-08-18 | $1.0M | — | Filing → |
| GTHX | SELL | 2021-07-15 | $946K | — | Filing → |